Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Angiogenesis-inhibitory activity reported for spironolactone

Nov. 21, 1996

Ansan starts new development program for chemotherapy-induced alopecia

Nov. 20, 1996

Sanofi introduces new platinum complex

Nov. 20, 1996

Tanabe to develop marimastat

Nov. 20, 1996

Johns Hopkins University reports antiproliferative vitamin D3 analogue

Nov. 20, 1996

400-C, new FPTase inhibitor reported by Schering-Plough

Nov. 20, 1996

FPTase inhibitior series reported by Schering-Plough

Nov. 20, 1996

Fujisawa describes new agents for thrombocytopenia

Nov. 20, 1996

New farnesyl protein transferase series synthesized at Merck & Co.

Nov. 20, 1996

Cysteine protease inhibitors revealed by Takeda

Nov. 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...